Rotating night shifts tied to heart disease risk

By Andrew M. Seaman (Reuters Health) – People who occasionally work night shifts may be at a slightly increased risk of heart disease, according to a new study. Nurses in the study who worked at least three nights per month were more likely to develop heart problems over the next 24 years than nurses who stuck to daytime shifts. “I think it’s an important message because it’s a potentially modifiable risk factor,” said lead author Celine Vetter, of Harvard Medical School andBrigham and Women’s Hospital in Boston.
Go to Source

Peru shoot-down law turns drug smugglers to boats, backpackers

A law in Peru that allows the military to shoot down planes suspected of smuggling drugs has forced traffickers to move cocaine out of a remote jungle region by boat and on foot, the prime minister said on Tuesday. The law, which ended a 15-year ban on the downing of civilian aircraft when it went into effect in January, intends to keep scores of small planes from flying drugs out of the Peruvian Amazon and into neighboring Bolivia and Brazil. Prime Minister Pedro Cateriano said that even though the military had not yet shot down any new planes, the threat of force had led to a sharp drop in the number of “narco-flights.” “Drug traffickers are using other routes to transport drugs, we’ve seen that in recent months,” Cateriano said at a press conference, citing police intelligence.
Go to Source

Valeant names Papa CEO after he resigns from Perrigo

Company logo of Valeant Pharmaceuticals International Inc is seen at its headquarters in Laval(Reuters) – Former Perrigo Co Plc head Joseph Papa was named Chief Executive Officer at Valeant Pharmaceuticals International on Monday, a role in which investors said he should focus on returning the company to growth. Papa will replace CEO Michael Pearson, whose years of frenzied dealmaking fueled double-digit profit increases at Valeant until scrutiny of its controversial relationship with a specialty pharmacy and history of sharp drug price increases hit its shares and sales last fall. Shares of Laval, Quebec-based Valeant rose on Monday after it announced the high-profile hire before losing about 2.2 percent in New York trading to close at $35.16.

Go to Source

1 2 3 4 11